Prothena | PRTA - Pre Tax Profit

Stock Price
8.65
Daily Change
0.01 0.12%
Monthly
-5.36%
Yearly
-45.29%
Q1 Forecast
8.74

Prothena reported $-36.91M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
ALKERMES USD 100.74M 4.1M Sep/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Exelixis USD 252.69M 275K Dec/2025
Immunic USD -21.38M 8.2M Jun/2024
Incyte USD 389.94M 92.37M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Prothena USD -36.91M 44.05M Sep/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Xoma USD 15.98M 24.58M Jun/2024